Lipoprotein(a) for risk assessment in patients with established coronary artery disease.
about
The relationship between Lp(a) and CVD outcomes: a systematic reviewPlasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria.Lipoprotein (a) measurements for clinical application.Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease riskLipoprotein(a) as a therapeutic target in cardiovascular disease.Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention.Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease.Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion.Lipoprotein(a): the revenant.Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults.Lipoprotein(a) and Increased Cardiovascular Risk in Women.Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial.Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22.NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
P2860
Q26749317-FE4F0962-34B0-4132-BB4A-44D8F9CFE8D8Q34662899-1400D6F5-EFEF-4583-ABA1-16862F1EC8FCQ36731801-38E912A0-ACB0-4937-AD81-B109C73D41A5Q36877240-69C5D7D5-2772-4A46-998B-885507499634Q37334501-21C783A8-D75C-4CD7-889B-D3006F7DC006Q38213476-412525C2-7EA5-4629-B15E-A67D9BBD0090Q38415231-5DFD6900-DCA4-4EA6-803F-1A06E0292656Q38752767-966BFFE4-9FDF-4E6C-94FF-883F21008377Q38985774-9584C247-5DD4-4296-AFEE-FA59D32A5F46Q39453691-CA16A66B-C0DB-4856-A9EC-E3FD1A8D1279Q39469427-CFDF9CB4-2FA8-43B3-9D78-43570D7D59CDQ40280257-66D9CAA9-8DE9-438B-88AA-F6F2037C20A8Q40469545-E23B9067-43F3-4164-BA68-A6C1B49E052BQ40755518-23A5A2CD-BD5C-4AA3-A2F2-10116BF3E1FFQ40908273-DA807F40-9B28-482D-B9DA-844563C164F9Q46744131-EE0AE80D-0A40-478B-B832-323B07C87F21Q47144487-D085D820-71BE-4EAA-B600-7A1CCFAFECD6Q47239892-6B3AB396-FFDE-4E8B-AFC3-61C7F8923F1EQ50081201-65786CC9-7408-48C0-B7D1-1A2D6FD6D946Q55253271-29A7D6BB-A40D-4EE2-B3AF-96345F593DF1
P2860
Lipoprotein(a) for risk assessment in patients with established coronary artery disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipoprotein(a) for risk assessment in patients with established coronary artery disease.
@en
type
label
Lipoprotein(a) for risk assessment in patients with established coronary artery disease.
@en
prefLabel
Lipoprotein(a) for risk assessment in patients with established coronary artery disease.
@en
P2093
P2860
P1476
Lipoprotein(a) for risk assessment in patients with established coronary artery disease.
@en
P2093
Angela F Ren
Christopher P Cannon
David A Morrow
Elaine B Hoffman
Frank M Sacks
Kiyohito Arai
Marc S Sabatine
Michael Domanski
Michelle L O'Donoghue
Nihar R Desai
P2860
P304
P356
10.1016/J.JACC.2013.09.042
P407
P577
2013-10-23T00:00:00Z